Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 207
115th Congress(2017-2018)
SALTS Act
Introduced
Introduced
Introduced in Senate on Jan 24, 2017
Overview
Text
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 207 (Reported-in-Senate)

Calendar No. 472

115th CONGRESS
2d Session
S. 207


To amend the Controlled Substances Act relating to controlled substance analogues.

IN THE SENATE OF THE UNITED STATES

January 24, 2017

Ms. Klobuchar (for herself, Mr. Graham, Mrs. Feinstein, Mr. Grassley, Mr. Whitehouse, Mr. Cornyn, Mr. Blumenthal, Mr. Tillis, Mr. Warner, Mr. Hatch, Ms. Hassan, Mr. Rubio, Mr. Markey, Mr. Kennedy, Ms. Smith, and Mr. Coons) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

June 19, 2018

Reported by Mr. Grassley, without amendment

A BILL

To amend the Controlled Substances Act relating to controlled substance analogues.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Synthetic Abuse and Labeling of Toxic Substances Act of 2017” or the “SALTS Act”.

SEC. 2. Controlled substance analogues.

Section 203 of the Controlled Substances Act (21 U.S.C. 813) is amended—

(1) by striking “A controlled” and inserting “(a) In general.—A controlled”; and

(2) by adding at the end the following:

“(b) Determination.—In determining whether a controlled substance analogue was intended for human consumption under subsection (a), evidence related to the following factors may be considered, along with all other relevant evidence:

“(1) The marketing, advertising, and labeling of the substance.

“(2) The known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose.

“(3) The difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold.

“(4) The diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance.

“(5) Whether the defendant knew or should have known the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.

“(c) Limitation.—For purposes of this section, the existence of evidence that a substance was not marketed, advertised, or labeled for human consumption shall not preclude the Government from establishing, based on all the evidence, that the substance was intended for human consumption.”.

Calendar No. 472

115th CONGRESS
     2d Session
S. 207
A BILL
To amend the Controlled Substances Act relating to controlled substance analogues.
June 19, 2018
Reported without amendment